Amgen EBITDA 2006-2019 | AMGN

Amgen annual and quarterly EBITDA history from 2006 to 2019. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Amgen EBITDA for the quarter ending June 30, 2019 was $3.179B, a 4.13% decline year-over-year.
  • Amgen EBITDA for the twelve months ending June 30, 2019 was $11.842B, a 2.21% decline year-over-year.
  • Amgen 2018 annual EBITDA was $12.209B, a 2.36% increase from 2017.
  • Amgen 2017 annual EBITDA was $11.928B, a 0.24% increase from 2016.
  • Amgen 2016 annual EBITDA was $11.899B, a 12.49% increase from 2015.
Amgen Annual EBITDA
(Millions of US $)
2018 $12,209
2017 $11,928
2016 $11,899
2015 $10,578
2014 $8,283
2013 $7,153
2012 $6,665
2011 $5,372
2010 $6,562
2009 $6,555
2008 $6,287
2007 $5,182
2006 $4,803
2005 $5,689
Amgen Quarterly EBITDA
(Millions of US $)
Q2 2019 $3,179
Q1 2019 $2,967
Q4 2018 $2,872
Q3 2018 $2,824
Q2 2018 $3,316
Q1 2018 $3,197
Q4 2017 $2,694
Q3 2017 $2,903
Q2 2017 $3,216
Q1 2017 $3,115
Q4 2016 $3,044
Q3 2016 $3,030
Q2 2016 $2,902
Q1 2016 $2,923
Q4 2015 $2,575
Q3 2015 $2,862
Q2 2015 $2,595
Q1 2015 $2,546
Q4 2014 $1,984
Q3 2014 $2,009
Q2 2014 $2,408
Q1 2014 $1,882
Q4 2013 $1,631
Q3 2013 $1,976
Q2 2013 $1,827
Q1 2013 $1,719
Q4 2012 $1,361
Q3 2012 $1,710
Q2 2012 $1,858
Q1 2012 $1,736
Q4 2011 $1,423
Q3 2011 $790
Q2 2011 $1,593
Q1 2011 $1,566
Q4 2010 $1,329
Q3 2010 $1,732
Q2 2010 $1,768
Q1 2010 $1,733
Q4 2009 $1,380
Q3 2009 $1,877
Q2 2009 $1,710
Q1 2009 $1,588
Q4 2008 $1,411
Q3 2008 $1,751
Q2 2008 $1,444
Q1 2008 $1,681
Q4 2007 $1,359
Q3 2007 $767
Q2 2007 $1,412
Q1 2007 $1,644
Q4 2006 $1,189
Q3 2006 $1,609
Q2 2006 $552
Q1 2006 $1,453
Q4 2005 $1,319
Q3 2005 $1,502
Q2 2005 $1,510
Q1 2005 $1,358
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $116.342B $23.747B
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
Stock Name Country Market Cap PE Ratio
Gilead Sciences (GILD) United States $84.042B 10.32
CSL (CSLLY) Australia $72.428B 0.00
Celgene (CELG) United States $69.903B 10.81
Vertex Pharmaceuticals (VRTX) United States $44.326B 47.90
Illumina (ILMN) United States $43.735B 51.38
Biogen (BIIB) United States $42.849B 7.61
Regeneron Pharmaceuticals (REGN) United States $31.212B 14.17
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.275B 12.80
SINO PHARMACEUT (SBMFF) China $17.750B 0.00
Incyte (INCY) United States $16.360B 48.15
Exact Sciences (EXAS) United States $14.074B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.065B 0.00
Genmab (GNMSF) Denmark $12.366B 69.36
Seattle Genetics (SGEN) United States $11.463B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.123B 54.27
Alnylam Pharmaceuticals (ALNY) United States $9.249B 0.00
Galapagos (GLPG) Belgium $8.775B 0.00
QIAGEN (QGEN) Netherlands $7.685B 25.24
Bio-Techne Corp (TECH) United States $7.575B 52.33
Guardant Health (GH) United States $7.163B 0.00
Sarepta Therapeutics (SRPT) United States $6.540B 0.00
BeiGene (BGNE) Cayman Islands $6.319B 0.00
Amarin (AMRN) Ireland $5.983B 0.00
Exelixis (EXEL) United States $5.834B 15.16
Bluebird Bio (BLUE) United States $5.699B 0.00
ACADIA Pharmaceuticals (ACAD) United States $5.655B 0.00
Moderna (MRNA) United States $5.415B 0.00
Horizon Pharma Public (HZNP) Ireland $4.928B 12.53
ARGENX SE-ADR (ARGX) Netherlands $4.772B 0.00
Ascendis Pharma (ASND) Denmark $4.406B 0.00
Repligen (RGEN) United States $4.071B 79.01
Spark Therapeutics (ONCE) United States $4.066B 0.00
China Biologic Products (CBPO) China $3.934B 24.56
Blueprint Medicines (BPMC) United States $3.880B 0.00
Medicines (MDCO) United States $3.852B 0.00
MorphoSys AG (MOR) Germany $3.692B 0.00
Alkermes (ALKS) Ireland $3.554B 0.00
Mirati Therapeutics (MRTX) United States $3.329B 0.00
Immunomedics (IMMU) United States $3.018B 0.00
Emergent Biosolutions (EBS) United States $2.794B 41.97
Genomic Health (GHDX) United States $2.710B 50.82
CRISPR Therapeutics AG (CRSP) Switzerland $2.626B 0.00
Arena Pharmaceuticals (ARNA) United States $2.620B 5.63
Ultragenyx Pharmaceutical (RARE) United States $2.578B 0.00
Reata Pharmaceuticals (RETA) United States $2.564B 0.00
MyoKardia (MYOK) United States $2.541B 0.00
Amicus Therapeutics (FOLD) United States $2.493B 0.00
Acceleron Pharma (XLRN) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.413B 0.00
NeoGenomics (NEO) United States $2.342B 125.28
Intercept Pharmaceuticals (ICPT) United States $2.226B 0.00
Myriad Genetics (MYGN) United States $2.040B 21.41
Cambrex (CBM) United States $2.010B 25.41
Zai Lab (ZLAB) China $1.964B 0.00
Akcea Therapeutics (AKCA) United States $1.957B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.855B 23.45
UniQure (QURE) Netherlands $1.838B 0.00
Denali Therapeutics (DNLI) United States $1.826B 0.00
Insmed (INSM) United States $1.696B 0.00
REGENXBIO (RGNX) United States $1.456B 0.00
Coherus BioSciences (CHRS) United States $1.391B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.369B 0.00
Alector (ALEC) United States $1.346B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.345B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Sangamo Therapeutics (SGMO) United States $1.285B 0.00
RA PHARMCTL INC (RARX) United States $1.178B 0.00
Innoviva (INVA) United States $1.176B 3.39
AnaptysBio (ANAB) United States $1.159B 0.00
Fate Therapeutics (FATE) United States $1.141B 0.00
Epizyme (EPZM) United States $1.105B 0.00
Athenex (ATNX) United States $1.085B 0.00
Zymeworks (ZYME) Canada $1.022B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.016B 0.00
Twist Bioscience (TWST) United States $0.941B 0.00
Cara Therapeutics (CARA) United States $0.921B 0.00
Principia Biopharma (PRNB) United States $0.882B 459.75
Arvinas (ARVN) United States $0.879B 0.00
ANI Pharmaceuticals (ANIP) United States $0.877B 14.64
BAVARIAN NORDIC (BVNRY) Denmark $0.843B 0.00
Codexis (CDXS) United States $0.829B 0.00
WAVE Life Sciences (WVE) Singapore $0.826B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.815B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.771B 0.00
Anika Therapeutics (ANIK) United States $0.756B 26.76
Cytokineticsorporated (CYTK) United States $0.739B 0.00
Zealand Pharma (ZEAL) Denmark $0.734B 8.51
Vericel (VCEL) United States $0.729B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.727B 26.25
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Intellia Therapeutics (NTLA) United States $0.721B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Mesoblast (MESO) Australia $0.636B 0.00
DBV Technologies S.A (DBVT) France $0.578B 0.00
Intra-Cellular Therapies (ITCI) United States $0.577B 0.00
Revance Therapeutics (RVNC) United States $0.572B 0.00
MiMedx (MDXG) United States $0.561B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.557B 0.00
Cellectis S.A (CLLS) France $0.535B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Precision BioSciences (DTIL) United States $0.506B 0.00
Retrophin (RTRX) United States $0.504B 0.00
Heska (HSKA) United States $0.500B 64.82
Autolus Therapeutics (AUTL) United Kingdom $0.498B 0.00
Syros Pharmaceuticals (SYRS) United States $0.492B 0.00
Stemline Therapeutics (STML) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.474B 0.00
PHARMA MAR SA (PHMMF) Spain $0.460B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.459B 0.00
Puma Biotechnology (PBYI) United States $0.451B 0.00
CytomX Therapeutics (CTMX) United States $0.440B 0.00
BioDelivery Sciences (BDSI) United States $0.424B 0.00
Agenus (AGEN) United States $0.422B 0.00
Arcus Biosciences (RCUS) United States $0.418B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.415B 0.00
Bellus Health (BLU) Canada $0.395B 0.00
Scholar Rock Holding (SRRK) United States $0.388B 0.00
Merus (MRUS) Netherlands $0.385B 0.00
Adverum Biotechnologies (ADVM) United States $0.384B 0.00
Protagonist Therapeutics (PTGX) United States $0.382B 0.00
Gritstone Oncology (GRTS) United States $0.365B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
AC Immune SA (ACIU) Switzerland $0.355B 26.25
Prothena (PRTA) Ireland $0.348B 0.00
Theratechnologies (THERF) Canada $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.319B 477.09
Albireo Pharma (ALBO) United States $0.318B 0.00
Clovis Oncology (CLVS) United States $0.312B 0.00
ADMA Biologics Inc (ADMA) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Pfenex (PFNX) United States $0.306B 0.00
Sorrento Therapeutics (SRNE) United States $0.304B 0.00
Avid Bioservices (CDMO) United States $0.304B 0.00
Geron (GERN) United States $0.298B 0.00
Starpharma Holdings (SPHRY) Australia $0.285B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Kindred Biosciences (KIN) United States $0.276B 0.00
MannKind (MNKD) United States $0.271B 0.00
PDL BioPharma (PDLI) United States $0.271B 6.97
Seres Therapeutics (MCRB) United States $0.270B 0.00
Prometic Life Sciences (PFSCF) Canada $0.266B 0.00
Cel-Sci (CVM) United States $0.266B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Senesco Technologies (ELOX) United States $0.258B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.257B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.256B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.251B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.240B 0.00
Spero Therapeutics (SPRO) United States $0.232B 0.00
ChromaDex (CDXC) United States $0.231B 0.00
Athersys (ATHX) United States $0.226B 0.00
Palatin Technologies (PTN) United States $0.216B 6.67
Five Prime Therapeutics (FPRX) United States $0.215B 0.00
Kamada (KMDA) Israel $0.213B 8.12
Compugen (CGEN) Israel $0.210B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.202B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EXICURE INC (XCUR) United States $0.195B 0.00
Affimed (AFMD) Germany $0.195B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.191B 0.00
OSMOTICA PHARM (OSMT) United States $0.191B 0.00
CorMedix Inc (CRMD) United States $0.188B 0.00
Acorda Therapeutics (ACOR) United States $0.185B 0.00
Arsanis (XFOR) United States $0.184B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.182B 0.00
Enzo Biochem (ENZ) United States $0.170B 0.00
XOMA (XOMA) United States $0.168B 0.00
POXEL SA FRANCE (PXXLF) France $0.167B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Emmaus Life Sciences (EMMA) United States $0.163B 0.00
Northwest Biotherapeutics (NWBO) United States $0.163B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.162B 0.00
Nicox SA (NICXF) France $0.161B 0.00
Cerecor (CERC) United States $0.161B 0.00
BioTime (LCTX) United States $0.156B 10.40
Abeona Therapeutics (ABEO) United States $0.155B 0.00
Alcobra (ARCT) United States $0.152B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.148B 0.00
PHASEBIO PHARMA (PHAS) United States $0.147B 0.00
Strongbridge Biopharma (SBBP) United States $0.146B 6.00
Dyadic (DYAI) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Novavax (NVAX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.131B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.128B 0.00
Menlo Therapeutics (MNLO) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.109B 0.00
Aduro Biotech (ADRO) United States $0.107B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.099B 0.00
Verastem (VSTM) United States $0.097B 0.00
Mersana Therapeutics (MRSN) United States $0.096B 0.00
Arbutus Biopharma (ABUS) Canada $0.093B 0.00
Vaccinex (VCNX) United States $0.089B 0.00
VTv Therapeutics (VTVT) United States $0.087B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Trevena (TRVN) United States $0.086B 0.00
Synlogic (SYBX) United States $0.083B 0.00
Selecta Biosciences (SELB) United States $0.082B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.081B 0.00
Antibe Therapeutics (ATBPF) Canada $0.080B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.080B 0.00
OvaScience (MLND) United States $0.079B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
Catalyst Biosciences (CBIO) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.073B 0.00
VBI Vaccines (VBIV) United States $0.072B 0.00
NewLink Genetics (NLNK) United States $0.072B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.068B 37.30
Curis (CRIS) United States $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ARAVIVE, INC (ARAV) United States $0.065B 0.00
AquaBounty Technologies (AQB) United States $0.065B 0.00
Pluristem Therapeutics (PSTI) Israel $0.063B 0.00
Unum Therapeutics (UMRX) United States $0.062B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
AIT Therapeutics (XAIR) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.049B 0.00
Ophthotech (ISEE) United States $0.049B 0.00
VistaGen Therapeutics (VTGN) United States $0.047B 0.00
Proteostasis Therapeutics (PTI) United States $0.047B 0.00
AmpliPhi Biosciences (ARMP) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.044B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.039B 0.00
Organovo Holdings (ONVO) United States $0.039B 0.00
Stellar Biotechnologies (EDSA) Canada $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.034B 0.00
BIOCARDIA INC (BCDA) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.033B 0.00
AEterna Zentaris (AEZS) United States $0.031B 0.00
Entera Bio (ENTX) Israel $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Clearside Biomedical (CLSD) United States $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Apricus Biosciences (SEEL) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 6.10
Pulmatrix (PULM) United States $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
IBio (IBIO) United States $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
Vical (BBI) United States $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Bionano Genomics (BNGO) United States $0.013B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.006B 0.00
Advaxis (ADXS) United States $0.005B 0.00
Hemispherx BioPharma (AIM) United States $0.005B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
Neuralstem (CUR) United States $0.004B 0.00